Emergent BioSolutions (EBS) Change in Accured Expenses (2010 - 2026)
Emergent BioSolutions (EBS) posted Change in Accured Expenses of $4.2 million for Q2 2026, up 120.79% on a QoQ basis from -$20.2 million in Q1 2026, and up 7.69% year-over-year from $3.9 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Change in Accured Expenses for 17 years, with the latest figure at $4.2 million in Q2 2026.
- On a quarterly basis, Change in Accured Expenses rose 7.69% year-over-year to $4.2 million in Q2 2026; TTM through Jun 2026 was -$5.0 million, a 87.34% increase from a year earlier, with the FY2025 full-year figure at -$17.3 million, up 4.95% from the prior year.
- Change in Accured Expenses was $4.2 million for Q2 2026 at Emergent BioSolutions, up from -$20.2 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $39.9 million in Q3 2024, with the low at -$51.1 million in Q4 2024.
- Average Change in Accured Expenses over 5 years is -$9.7 million, with a median of -$14.2 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses plunged 281.19% in 2022, then jumped 343.29% in 2024.
- Over 5 years, Change in Accured Expenses stood at -$18.3 million in 2022, then slumped by 39.34% to -$25.5 million in 2023, then sank by 100.39% to -$51.1 million in 2024, then jumped by 118.98% to $9.7 million in 2025, then plunged by 56.7% to $4.2 million in 2026.
- The last three Change in Accured Expenses figures came in at $4.2 million (Q2 2026), -$20.2 million (Q1 2026), and $9.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 2.32 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 1.20 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 360.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | - |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 212.44 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 55.78 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 4.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.20 Mn |
| Mar 31, 2026 | -20.20 Mn |
| Dec 31, 2025 | 9.70 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | -32.20 Mn |
| Dec 31, 2024 | -51.10 Mn |
| Sep 30, 2024 | 39.90 Mn |
| Jun 30, 2024 | 26.30 Mn |
| Mar 31, 2024 | -33.30 Mn |
| Dec 31, 2023 | -25.50 Mn |
| Sep 30, 2023 | -16.40 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | -24.30 Mn |
| Dec 31, 2022 | -18.30 Mn |
| Sep 30, 2022 | -12.00 Mn |
| Jun 30, 2022 | 14.60 Mn |
| Mar 31, 2022 | -51.00 Mn |
| Dec 31, 2021 | 10.10 Mn |
| Sep 30, 2021 | 36.10 Mn |
API Access
Emergent BioSolutions Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();